Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2025
[Pathogenesis and therapeutic advances in skeletal muscle atrophy associated with chronic heart failure: a discussion from perspective of heart Yin deficiency].
СтатьяОбзорАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Si-Jing, Li Zi-Ru, Zhang Xiao-Jiao, He Xing-Ling, Chen Jia-Hui, Dong Xiao-Ming, Long Wen-Jie, Liu Jian-Hong, Liao Hui-Li, Lu Lu, Yang Zhong-Qi, Ni Shi-Hao
Аннотация
Chronic heart failure(CHF) represents the terminal phase of severe cardiovascular diseases, with concomitant skeletal muscle atrophy significantly compromising patients' motor function and quality of life, as well as increasing risks of adverse clinical outcomes. Current therapeutic agents and interventions targeting CHF-associated muscle atrophy remain limited. Grounded in a holistic approach and syndrome differentiation, traditional Chinese medicine(TCM) offers unique advantages in managing CHF comorbidities. This review explored the pathological mechanisms underlying skeletal muscle atrophy in CHF through the lens of the "heart Yin deficiency" theory in TCM. A pathogenic triad was proposed, encompassing collateral malnutrition due to Yin deficiency, toxin-stasis interaction, and physical-mental exhaustion. The triad was examined in relation to modern biomedical mechanisms including neuroendocrine dysregulation, oxidative stress-inflammation, microcirculatory dysfunction, and protein metabolic imbalance, highlighting the central role of heart Yin deficiency in disease progression. From the therapeutic perspective of nourishing heart Yin, the multi-target effects of herbal compound formulae and acupuncture therapy in improving cardiac function and alleviating muscle atrophy were analyzed. This analysis aims to provide both theoretical foundations and practical guidance for the clinical management of CHF with skeletal muscle atrophy.